Page not found

×

Warning message

Your search used too many AND/OR expressions. Only the first 7 terms were included in this search.

Search results

  1. Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial

    ... been cleared by the U.S. Food and Drug Administration for use in phase 1 clinical trials—the third WCNDD therapeutic to reach that ... collaboration was facilitated by the   Center for Technology Transfer and Commercialization . Vanderbilt researchers who ...

    sommers - 01/17/2024 - 10:08am

  2. Novel anti-platelet therapy for treatment of thrombosis, cardiovascular disease, and cerebrovascular injury

    Technology Description Cardiovascular disease remains one of the ... Vanderbilt researchers have recently developed novel PAR4 antagonists with potential benefits for patients that minimize severe bleeding ... Therapeutics Field of Use: Cardiovascular Featured:  ...

    cttc_admin - 01/23/2024 - 1:42pm

  3. Taking a bite out of Charcot-Marie-Tooth Disease

    ... manager of corporate alliances for Vanderbilt’s Center for Technology Transfer and Commercialization,  attended a global conference ... showed her the facilities and the instrumentation that we use to conduct biophysical and cell biology studies on PMP22, which include CMT ...

    sommers - 03/18/2024 - 1:36pm

  4. Oral administration of levocarnitine for treating Sjögren's Syndrome-associated dry eye

    ... provide only temporary relief from symptoms. The proposed technology of oral levocarnitine administration offers a novel approach for ... Therapeutics Field of Use: Opthamology Featured:  ...

    cttc_admin - 02/15/2024 - 1:31pm

  5. Small Molecule mGlu3 NAMs as Therapeutics for CNS Disorders

    ... many neurological disorders and well as oncology through the use of dual specific mGlu2/3 Antagonists (LY341495, RO4491533, MGS0039, RO4988546). These dual specific ...

    cttc_admin - 01/23/2024 - 4:43pm

  6. Small Molecule-GIRK Potassium Channel Modulators That Are Anxiolytic Therapeutics

    ... of animals tested that experienced convulsions from PTZ treatment and in (c) the percentage of animals that survived PTZ treatment. In ... Therapeutics Field of Use: Analgesic ...

    cttc_admin - 01/23/2024 - 1:38pm

  7. Anti-inflammatory microparticles for sustained ocular drug delivery

    ... gold standard poly(lactic-co-glycolic acid) (PLGA). Technology Description To overcome these challenges, Vanderbilt ... Therapeutics Field of Use: Inflammatory/Immune/Wound Repair ...

    cttc_admin - 02/01/2024 - 12:21pm

  8. Use of Fluid Shear Stress Treatment to Enhance T Cell Activation

    ... effective in activating all types of T cells.   Technology Description Vanderbilt scientists have pioneered a method ... Therapeutics Field of Use: Inflammatory/Immune/Wound Repair ...

    cttc_admin - 01/18/2024 - 9:10am

  9. Discovery Vanderbilt invests in three faculty-initiated startups: HeroWear, IDBiologics and Virtuoso

    ... the  Center for Rehabilitation Engineering and Assistive Technology  by  Karl Zelik , associate professor of mechanical ... and commercialization by HeroWear and for field use by the Army. This month, HeroWear introduced its newest commercially ... IDBiologics  develops human monoclonal antibodies for the treatment and prevention of major infectious diseases, including SARS-CoV-2, ...

    sommers - 05/23/2023 - 12:14pm

  10. Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University

    ... with the ultimate goal of aiding precision medicine in the use of immunotherapy in breast cancer and other tumor types. Migrating this ... and protein biomarker platform and LDTs, Theralink’s technology targets multiple areas of oncology and drug development. In addition ...

    sommers - 04/24/2023 - 1:45pm